MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

Clinical trial NCT01225666 · COMPLETED

Trial details

NCT number: NCT01225666
Sponsor: OPKO Health, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Growth Hormone Deficiency

Start date: 2010-08-01
Primary completion: 2011-07-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.